Ready 8-Ks
40
Latest filing
July 23, 2026, 7:03 AM ET
Top materiality
0.85
Event mix
earnings ×21 · other_material ×6 · leadership ×6
Sentiment
21 pos · 1 neg · 18 neu
Latest earnings
reported 2026-Q1
-
Visteon Q2 net income $49M, EPS $1.80; launches $200M ASR
Net sales $960M (down ~1% YoY); net income $49M; diluted EPS $1.80.
-
Visteon board authorizes $800M share repurchase program through Dec 2029
Board authorized $800 million share repurchase program expiring December 31, 2029.
-
Visteon Q1 2026 sales $954M (+2% YoY), net income $31M; reaffirms full-year guidance
Sales $954M (+2% YoY, 3% growth-over-market); net income $31M ($1.14 diluted EPS); adjusted EBITDA $104M.
-
Visteon reports record adjusted EBITDA $492M in 2025; raises dividend 36% to $0.375
Q4 net sales $948M; full-year net sales $3,768M; net income $201M ($7.28 diluted EPS); adjusted EPS $2.96 in Q4.
-
Visteon Q3 sales $917M, adj EPS $2.15, margin expands, initiates dividend
Net income $57M; diluted EPS $2.04, adjusted EPS $2.15 (non-GAAP).
-
Visteon Q2 net income $65M ($2.36 EPS), initiates $0.275 quarterly dividend, raises FY guidance
Q2 sales $969M (down 4.4% YoY from $1,014M); net income $65M, adjusted EBITDA $134M.
-
Visteon Q1 2025: sales $934M, net income $65M; withdraws FY guidance on tariff uncertainty
Net sales $934M (flat YoY), net income $65M, diluted EPS $2.36, adjusted EBITDA $129M.
-
Visteon reports record adjusted EBITDA of $474M in 2024; guides 2025 sales $3.65-3.85B
Q4 net sales $939M, net income $122M ($4.37 EPS); full-year net sales $3.866B, net income $274M ($9.82 EPS).
-
Visteon Q3 2024 sales $980M, adj. EPS $2.26, updates FY2024 guidance
Sales $980M, 6% growth-over-market; net income $39M ($1.40 diluted EPS); adj. net income $63M ($2.26 diluted EPS).
-
Visteon Q2 sales $1.01B, record Adj EBITDA $136M; FY2024 guidance updated
Sales $1,014M (+3% YoY); net income $71M ($2.54 EPS); Growth-over-Market 9%.
-
Visteon Q1 net sales $933M (-3.5% YoY), adj. EBITDA $102M (10.9% of sales, +70bps)
Net income $42M ($1.50 diluted EPS); new business wins $1.4B including >$400M displays.
-
Visteon reports record FY 2023 sales $3.95B, adj EBITDA $434M; CEO term extended to 2030
Q4 net sales $990M (down 7% YoY), base sales up 1%; net income $366M includes $313M non-cash U.S. tax benefit.
-
Visteon Q3 adjusted EBITDA $128M, up 35% YoY; updates FY guidance
Sales $1,014M; base sales up 9% YoY, 18th consecutive quarter of growth-over-market.
-
Visteon Q2 sales up 18% to $983M; adj. EBITDA $90M; reiterates FY guidance
Sales $983M, up 18% YoY (ex-FX); net income $20M; adj. net income $34M, adj. EPS $1.18.
-
Visteon Q1 sales $967M (+22% ex-currency), net income $34M, FY guidance reaffirmed
Sales of $967M, up 22% YoY excluding currency; 16th consecutive quarter of growth over market.
-
Visteon beats Q4 outlook with net sales up 35% YoY; guides 2023 sales $3.95-$4.15B
Q4 net sales $1,064M (+35% YoY); net income $34M ($1.18 EPS); adjusted EBITDA $103M (9.7% of sales).
-
Visteon Q3 sales up 63% to $1,026M; net income $44M; raises FY guidance
Sales $1,026M (+63% YoY); net income $44M or $1.54 diluted EPS.
-
Visteon Q2 sales up 42% to $848M; net income $24M, adj. EBITDA $79M
Net sales $848M, up 42% YoY ex-FX, driven by new launches and semiconductor cost pass-through.
-
Visteon enters credit amendment: $400M revolver, new term A facility maturing 2027
New $400M revolving credit facility replaces existing revolver; new term loan A refinances prior term loans.
-
Visteon Q1 sales $818M, up 11%; net income $22M; maintains FY 2022 guidance
Sales $818M, up 11% YoY (ex-currency); growth-over-market of 22% versus top customers' production.
-
Visteon Q4 net sales $786M, net income $31M; guides 2022 sales $3.15-3.35B
Q4 2021 net sales $786M (flat YoY, 15% growth-over-market); net income $31M ($1.09 diluted EPS).
-
Visteon Q3 net income $5M, sales $631M (-17% YoY); lowers FY guidance
Net income $5M ($0.18 diluted EPS); adjusted EBITDA $42M (6.7% of sales), down $45M YoY.
-
Visteon Q2 sales up 59% Y/Y to $610M; net loss narrows to $11M
Net loss of $11M ($0.39 diluted loss) vs. prior year loss of $53M; adjusted EBITDA $30M (4.9% of sales), up $33M Y/Y.